Japan's Ministry of Health, Labor and Welfare approved Shionogi new crown oral drug EUA
On November 22, Japan's Ministry of Health, Labor and Welfare approved Shionogi new crown oral drug EUA.
Previously, on September 28, Shionogi announced that the Phase III portion of a Phase II/III clinical trial of the 3CL protein inhibitor Ensitrelvir Fumaric Acid (S-217622) in Asia met the primary endpoint.
The results showed that, for the first time, ensitrelvir was shown to significantly reduce the time to remission of the five typical symptoms of Omicron compared to placebo. At the same time, ensitrelvir also showed a significant reduction in viral RNA load on day 4 (after the third dose).
This is the second 3CL drug after Pfizer paxlovid. The difference is that paxlovid needs to be used in combination with ritonavir. Enstirelvir alone can be effective.
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-08-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Australia Launches Anti-Circumvention Trade Probe into China’s 2,4-D Supply Chain
-
Deméter Enters China with a Stress-Focused Pitch
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
India’s API Trade Balance Turns Positive
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
US Tariff Refunds Could Reshape Seafood Trade
-
Hormuz Closure Raises Cold-Chain Risk
-
Hormuz Closure Raises Cold-Chain Risk
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
-
Middle East Conflict Hits China Seafood Trade
Recommend Reading
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
U.S. EPA Targets Perchlorate: A New Safety Line Drawn in Drinking Water Standards
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
ADAMA Targets Sucking Pests with Ateka
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Supply Contraction Meets Weak Consumption—PCs Consolidate in Early May
-
Premium Global Chemical Sourcing Requests (07-10May, 2026)
-
2025 Review and 2026 Outlook of the Methanol Market in China